1 results match your criteria: "Ludwig Cancer Research at University of Lausanne[Affiliation]"
Sci Transl Med
April 2016
Ludwig Cancer Research at University of Lausanne, 1066 Epalinges, Switzerland.
Cancer vaccine development has been vigorously pursued for 40 years. Immunity to tumor antigens can be elicited by most vaccines tested, but their clinical efficacy remains modest. We argue that a concerted international effort is necessary to understand the human antitumor immune response and achieve clinically effective cancer vaccines.
View Article and Find Full Text PDF